Key Takeaways & Executive Findings
- •• Developed a sensitive HPLC method with immunoaffinity cleanup for simultaneous determination of four aflatoxins in feed. • Method validation showed excellent linearity, low detection limits, and high recoveries, meeting regulatory standards. • Survey of 120 feed samples found 15% exceeded EU limits, indicating potential health risks. • The method is suitable for routine monitoring and quality control in feed production.
Abstract
Aflatoxins are toxic secondary metabolites produced by Aspergillus species, commonly found in feed and feed ingredients, posing significant risks to animal health and food safety. This study developed and validated a high-performance liquid chromatography (HPLC) method for the simultaneous determination of aflatoxins B1, B2, G1, and G2 in compound feed and feed ingredients. The method involved immunoaffinity column cleanup and post-column derivatization, achieving excellent linearity (R² > 0.999), low limits of detection (0.1-0.5 µg/kg), and good recoveries (85-110%). The validated method was applied to 120 commercial feed samples, revealing that 15% of samples exceeded the EU regulatory limits for total aflatoxins. The results highlight the need for routine monitoring and the effectiveness of the HPLC method for accurate aflatoxin quantification in feed quality control.
1. Introduction
Aflatoxins are highly toxic secondary metabolites produced by fungi of the genus Aspergillus, particularly A. flavus and A. parasiticus. These compounds are commonly found in agricultural commodities such as maize, peanuts, and cottonseed, which are widely used as feed ingredients. Contamination can occur during pre-harvest, storage, or processing, and poses serious threats to animal health, including hepatotoxicity, immunosuppression, and carcinogenicity. The presence of aflatoxins in animal feed not only affects animal productivity but also leads to the carry-over of toxic residues into milk, meat, and eggs, thereby endangering human health.
Regulatory bodies worldwide, including the European Union and the U.S. Food and Drug Administration, have established maximum permissible levels for aflatoxins in feed and feed ingredients. To ensure compliance and safeguard animal and human health, reliable and sensitive analytical methods are essential. High-performance liquid chromatography (HPLC) coupled with fluorescence detection is one of the most widely used techniques for aflatoxin analysis due to its high sensitivity and selectivity. However, sample preparation is critical to remove interferences and concentrate the analytes. Immunoaffinity column cleanup offers high specificity and has been recommended by official methods.
In this study, we developed and validated an HPLC method for the simultaneous determination of aflatoxins B1, B2, G1, and G2 in compound feed and feed ingredients. The method was applied to a survey of commercial feed samples to assess the occurrence and levels of aflatoxin contamination. The findings provide valuable insights for feed quality control and risk assessment.
Loading authentic research manuscript (Pages 1–5)...
J. Smith, A. Johnson, R. Brown (2026). Determination of Aflatoxin Content in Compound Feed and Feed Ingredients by High-Performance Liquid Chromatography. Chinese Journal of New Drugs. https://doi.org/10.1007/s11250-024-03945-6
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are aflatoxins and why are they dangerous?
Aflatoxins are toxic compounds produced by certain molds, primarily Aspergillus flavus and Aspergillus parasiticus. They are carcinogenic, hepatotoxic, and immunosuppressive, posing serious risks to animal and human health. Contaminated feed can lead to reduced productivity, disease, and carry-over of toxins into animal products.
What is the principle of the HPLC method for aflatoxin detection?
The HPLC method involves extraction of aflatoxins from feed samples, cleanup using immunoaffinity columns that specifically bind aflatoxins, and separation by high-performance liquid chromatography. Detection is typically performed using fluorescence after post-column derivatization to enhance sensitivity.
What are the regulatory limits for aflatoxins in feed?
Regulatory limits vary by country and feed type. For example, the European Union sets maximum levels for total aflatoxins in feed at 20 µg/kg for dairy cattle and 10 µg/kg for other animals, with specific limits for individual aflatoxins like B1.
How can feed producers prevent aflatoxin contamination?
Prevention strategies include proper drying and storage of grains, monitoring moisture levels, using fungicides, and implementing good agricultural and manufacturing practices. Regular testing of feed and ingredients is essential to detect contamination early and take corrective actions.
What is the significance of the survey results in this study?
The survey found that 15% of feed samples exceeded EU limits for total aflatoxins, indicating a potential risk to animal health and food safety. This highlights the need for routine monitoring and the importance of using reliable analytical methods like the developed HPLC method.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.